# FDA Inspection 1110555 - Harry Earl Studdard, MD - November 07, 2019

Source: https://www.keypedia.com/records/fda_inspections/harry-earl-studdard-md/0fc8722a-3144-4097-8dc3-012c8c83e5fb
Source feed: FDA_Inspections

> FDA Inspection 1110555 for Harry Earl Studdard, MD on November 07, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1110555
- Company Name: Harry Earl Studdard, MD
- Inspection Date: 2019-11-07
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1255107 - 2024-11-06](https://www.keypedia.com/records/fda_inspections/harry-earl-studdard-md/f45d47ce-23b6-426f-bb0a-dff67648f220)
- [FDA Inspection 1255107 - 2024-11-06](https://www.keypedia.com/records/fda_inspections/harry-earl-studdard-md/3db31e08-c8ac-4f43-be9c-81b69a5c78fe)
- [FDA Inspection 768727 - 2012-02-15](https://www.keypedia.com/records/fda_inspections/harry-earl-studdard-md/74de8604-7ac6-40fd-8168-375c964541bd)

Company: https://www.keypedia.com/companies/harry-earl-studdard-md/5cf3813d-ed00-4dc3-ba4b-3f44a49fa61f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d